The buzzword these days in quality improvement is “HIIN.” That’s short for Hospital Improvement Innovation Networks, part of the continuation of the Partnership for Patients program. It succeeds the recently concluded Hospital Engagement Networks and will work to reduce overall hospital-acquired conditions by 20% and 30-day hospital readmissions by 12%. The AHA’s Health Research & Educational Trust led the largest HEN project, which marked a concerted effort by more than 1,500 hospitals to improve the quality of patient care. Now, HRET will lead the largest of the 16 HIIN networks, with the goal of engaging more than 1,700 hospitals across 32 states. HIINs will build on what the HEN projects achieved: the saving of more than 87,000 lives and $19.8 billion in health care costs. AHA and HRET will align quality improvement efforts to expand our reach and accelerate the journey towards higher reliability and zero tolerance for error. Join your colleagues in the HRET HIIN for this worthy endeavor. It’s another great opportunity to demonstrate your commitment to spreading innovation and making health care safer for patients and families. Sign up at http://www.hret-hiin.org/.

Related News Articles

Headline
About 80 percent of new HIV infections in the U.S. in 2016 were transmitted from the nearly 40 percent of people with HIV who either did not know they had HIV…
Headline
Historic flooding in parts of the Midwest caused a number of Nebraska hospitals to be inaccessible by ground transportation, the Nebraska Hospital Association…
Headline
The Senate Appropriations Committee’s Subcommittee on Labor, Health and Human Services, Education and Related Agencies today held a
Insights and Analysis
In this AHA Stat Blog, Institute for Diversity and Health Equity President and CEO Duane Reynolds shares some takeaways from the recent ACHE conference and…
Insights and Analysis
This week, as part of the South by Southwest (SXSW) festival’s Interactive Health and MedTech track, the American Hospital Association and hospital leaders…
Headline
A federal court has ordered a Texas-based company to stop producing compounded drug products intended to be sterile until the company complies with the Federal…